KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 43.66%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 11.49%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 8.59%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 3,250.86%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 22.98%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 4.00%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 5.75%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 6.17%
10 Gsk 88.34 Bn 83.66 Bn - 4.70%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.17%
Dec 31, 2025 5.70%
Sep 30, 2025 6.46%
Jun 30, 2025 7.71%
Mar 31, 2025 6.86%
Dec 31, 2024 7.37%
Sep 30, 2024 6.51%
Jun 30, 2024 7.71%
Mar 31, 2024 7.50%
Dec 31, 2023 6.25%
Sep 30, 2023 7.39%
Jun 30, 2023 6.45%
Mar 31, 2023 3.84%
Dec 31, 2022 3.41%
Sep 30, 2022 2.85%
Jun 30, 2022 3.02%
Mar 31, 2022 4.93%
Dec 31, 2021 2.77%
Sep 30, 2021 2.23%
Jun 30, 2021 0.31%
Mar 31, 2021 -5.71%
Dec 31, 2020 -5.85%
Sep 30, 2020 18.84%
Jun 30, 2020 19.14%
Mar 31, 2020 22.61%
Dec 31, 2019 24.37%
Sep 30, 2019 -5.15%
Jun 30, 2019 -4.55%
Mar 31, 2019 -1.48%
Dec 31, 2018 0.52%
Sep 30, 2018 1.56%
Jun 30, 2018 2.75%
Mar 31, 2018 0.80%
Dec 31, 2017 0.42%
Sep 30, 2017 4.68%
Jun 30, 2017 7.55%
Mar 31, 2017 12.68%
Dec 31, 2016 12.87%
Sep 30, 2016 12.73%
Jun 30, 2016 5.36%
Mar 31, 2016 3.05%
Dec 31, 2015 -0.11%
Sep 30, 2015 -3.15%
Jun 30, 2015 -1.69%
Mar 31, 2015 -3.61%
Dec 31, 2014 -3.54%
Sep 30, 2014 -16.21%
Jun 30, 2014 -15.11%
Mar 31, 2014 -14.72%
Dec 31, 2013 -14.14%
Sep 30, 2013 -1.15%
Jun 30, 2013 16.75%
Mar 31, 2013 16.56%
Dec 31, 2012 17.96%
Sep 30, 2012 17.92%
Jun 30, 2012 -1.67%
Mar 31, 2012 -2.00%
Dec 31, 2011 -3.07%
Sep 30, 2011 -4.89%
Dec 31, 2010 -7.73%
Sep 30, 2010 -15.07%